Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | N/A | 8,688 | 21,393 | 46,620 |
| TOTAL | $0 | $N/A | $8,754 | $21,477 | $46,909 |
| Non-Current Assets | |||||
| PPE Net | 0 | N/A | 3 | 8 | 32 |
| TOTAL | $N/A | $N/A | $3 | $8 | $32 |
| Total Assets | $0 | $N/A | $8,757 | $21,485 | $46,941 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 1,880 | 1,969 | 2,090 |
| Accrued Expenses | 0 | N/A | 779 | 949 | 834 |
| TOTAL | $0 | $N/A | $2,659 | $2,918 | $2,924 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -140,126 | 0 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $N/A | $2,659 | $2,918 | $2,924 |
| Shareholders' Equity | |||||
| Common Shares | 0 | N/A | 26 | 24 | 24 |
| Retained earnings | 0 | N/A | -319,529 | -302,256 | -273,064 |
| Other shareholders' equity | 0 | 0 | -380 | -380 | -380 |
| TOTAL | $0 | $N/A | $6,098 | $18,567 | $44,017 |
| Total Liabilities And Equity | $0 | $0 | $8,757 | $21,485 | $46,941 |